Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 11, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jpm11060529
Keywords
heart failure; cardiovascular diseases; iPSCs cardiomyocyte; platforms; cardiopatches; exosomes; innate immunity; 2D and 3D models
Funding
- Deutsche Sonderforschungsbereich 1002
- European Research Council [ERC. StG 758087]
Ask authors/readers for more resources
Cardiovascular diseases are a major cause of death worldwide. Recent advancements in cardiac tissue engineering and iPSC reprogramming have shown promise in cardiovascular regeneration. These approaches offer potential in studying molecular mechanisms of heart diseases and developing new therapies.
Cardiovascular diseases are the leading cause of mortality worldwide. Understanding the mechanisms at the basis of these diseases is necessary in order to generate therapeutic approaches. Recently, cardiac tissue engineering and induced pluripotent stem cell (iPSC) reprogramming has led to a skyrocketing number of publications describing cardiovascular regeneration as a promising option for cardiovascular disease treatment. Generation of artificial tissue and organoids derived from induced pluripotent stem cells is in the pipeline for regenerative medicine. The present review summarizes the multiple approaches of heart regeneration with a special focus on iPSC application. In particular, we describe the strength of iPSCs as a tool to study the molecular mechanisms driving cardiovascular pathologies, as well as their potential in drug discovery. Moreover, we will describe some insights into novel discoveries of how stem-cell-secreted biomolecules, such as exosomes, could affect cardiac regeneration, and how the fine tuning of the immune system could be a revolutionary tool in the modulation of heart regeneration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available